+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 40Years
FEMALE
ID04650880

Vitamin D Supplementation to Improve Ovulation in Women Ages 18 to 40 With Polycystic Ovary Syndrome

Led by The University of Hong Kong · Updated on 2024-05-14

220

Participants Needed

3

Research Sites

104 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effect of vitamin D supplementation on ovulation rates in women with polycystic ovary syndrome PCOS. This randomized, double-blind controlled trial focuses on women diagnosed with PCOS by the Rotterdam criteria who experience irregular menstrual cycles and anovulation. The study aims to assess ovulation and other reproductive, endocrine, and metabolic outcomes over one year of treatment. Participants will be randomly assigned to either a vitamin D group or a placebo group. The vitamin D group will take 50,000 IU weekly for 4 weeks, then 50,000 IU every two weeks for 52 weeks. Participants who remain anovulatory after 6 months in both groups will receive a 6-month course of letrozole to induce ovulation. The placebo group will receive tablets that look like vitamin D but contain no active ingredient. During the study, participants will undergo transvaginal ultrasounds and blood tests to monitor ovulation, hormone levels, and other health indicators. Researchers will track ovulation rate as the primary outcome, along with pregnancy rates, live births, metabolic measures, and body measurements for up to 12 months. The study includes safety monitoring related to vitamin D levels and calcium. Total participation lasts about one year.

CONDITIONS

Brief Title

Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary Syndrome

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here